The aminoglycoside and macrolide antibiotic families have been shown to promote the read-through of nonsense mutations in the APC gene, decreasing oncogenic phenotypes in CRC cells and multiple mouse models [190]. The gene discussed is APC; the disease is colorectal carcinoma.